GGrantIndex
Sort

16,300 grants matching fatty liver disease

Myeloid-specific IRE1alpha as a mediator of nonalcoholic fatty liver disease

$71,734
William Reid Bolus · University Of California, San Francisco · F32 · FY2022 · DK

Diet-Induced Insulin Resistance in a Murine Fatty Acid Oxidation Disorder

$71,540
Melanie B Gillingham · Oregon Health & Science University · R03 · FY2010 · DK

Effect of Organophoshate Exposure on Cholesteryl Ester Hydrolase

$71,500
Matthew K Ross · Mississippi State University · R15 · FY2009 · ES

Elucidating dietary fructose and alcohol interactions during liver cancer development

$71,453
Cholsoon Jang · University Of California-Irvine · R01 · FY2023 · AA

Mechanism by which SGLT2 inhibitor treatment regulates skeletal muscle fuel metabolism

$71,340
Matthew McHutcheson Robinson · Oregon State University · R56 · FY2024 · DK

CLINICAL TRIAL: NON-ALCOHOLIC STEATOHEPATITIS CLINICAL RESEARCH NETWORK

$71,339
Joel Edward Lavine · University Of California, San Diego · M01 · FY2009 · RR

A Pilot Study of Losartan in the Treatment of Pediatric NAFLD

$71,225
Miriam B. Vos · Emory University · R03 · FY2014 · DK

Genetics of Type 2 Diabetes

$71,167
Steven C Elbein · Univ Of Arkansas For Med Scis · R01 · FY2009 · DK

METABOLIC ABNORMALITIES IN NON-ALCOHOLIC STEATOHEPATITIS

$71,162
Indiana Univ-Purdue Univ At Indianapolis · R03 · FY2000 · DK

Pilot Trial UO1 DUR-928

$71,108
Craig J McClain · University Of Louisville · U01 · FY2020 · AA

HIF regulation of Ammonia Processing and Fibrosis in MASLD/MASH

$71,020
Marc Cantwell · University Of Michigan At Ann Arbor · F32 · FY2025 · DK

The role of endocannabinoids in circadian disruption induced metabolic dysregulation

$70,867
Ilia Nicholas Karatsoreos · University Of Massachusetts Amherst · R01 · FY2023 · DK

QUANTITATION OF FACTORS REGULATING GLUCOSE TOLERANCE

$70,745
University Of Southern California · R01 · FY2001 · DK

Biospecimen & Biomarker Development Core

$70,680
Michael E. Scheurer · Baylor College Of Medicine · P01 · FY2023 · CA

Impact of dysbiosis on the development of age-related inflammation

$70,596
Vishwa Deep Dixit · Yale University · R01 · FY2022 · AG

Impact of dysbiosis on the development of age-related inflammation

$70,596
Vishwa Deep Dixit · Yale University · R01 · FY2021 · AG

Hepatitis C Clinical Trials-Clinical Center

$70,589
William H Lee · Ut Southwestern Medical Center · N01 · FY2009 · DK

Novel roles for Maf1 as a central regulator of lipid homeostasis

$70,574
Sean P. Curran · University Of Southern California · R01 · FY2017 · GM

Melanocortin-3 Receptor Regulation of Physical Activity and Metabolism

$70,404
Andrew Alistair Butler · Lsu Pennington Biomedical Research Ctr · R01 · FY2009 · DK

The role of AEG-1 in NASH and NASH-HCC

$70,363
Devanand Sarkar · Virginia Commonwealth University · R01 · FY2024 · DK

Cincinnati Children's Clinical Center for Targeting the Pathophysiology of Youth-Onset Type 2 Diabetes

$70,344
Amy Sanghavi Shah · Cincinnati Childrens Hosp Med Ctr · U01 · FY2023 · DK

Prostate and Cardiovascular Effects of Male Hormonal Contraceptive Regimens

$70,186
William J Bremner · University Of Washington · U54 · FY2007 · HD

QUANTITATION OF FACTORS REGULATING GLUCOSE TOLERANCE

$70,148
University Of Southern California · R01 · FY2000 · DK

Community Outreach and Translation Core (Hricko)

$70,105
Andrea M Hricko · University Of Southern California · P01 · FY2016 · ES

Trimming the fat with small proteins: Micropeptides in adipogenesis

$70,082
Victor Jieh Pong Pai · Salk Institute For Biological Studies · F32 · FY2022 · DK